Patent ID: 7374753
Filing Date: 2008-05-20
Classification: A61K,A61P,C12N,Y02A

Abstract:
1. A method of reducing a bacterial gastrointestinal infection in a human, said bacterial gastrointestinal infection selected from the group consisting of Clostridium perfringens, Clostridium difficile, Clostridium botulinum, Clostridium tributrycum, Clostridium sporogenes, Escherichia coli, Pseudomonas aeruginosa , and Staphylococcus aureus , comprising the steps of: a) orally administering to a human subject in need thereof a composition comprising: b) allowing said non-pathogenic lactic acid bacteria to grow in the human subject's gastrointestinal tract, thereby reducing a bacterial gastrointestinal infection.